glp-1 drug shortages FDA says that the shortage is over Medical student and researcher Ashwin
Description
Multiple targets The next generation of GLP-1 drugs is already entering the clinic with a shift to dual and triple agonists
Obes Surg 35(3):11271134 [DOI] [PubMed] [Google Scholar] 60.Esparham A et al (2024) Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: a systematic review and meta-analysis
When evaluating cost, do not just compare sticker prices

A high-sensitivity C-reactive protein (hsCRP) test is a sensitive version of a CRP test
doi: 10.1016/j.pharmthera.2020.107503

This was based on some of her conversations with obese patients
